H E Broxmeyer1. 1. Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, USA.
Abstract
OBJECTIVES: To review information on cord blood banking and transplantation with respect to the author's studies, and in context of this field of investigation. RESULTS: Cord blood transplantation has been successfully used to treat a number of malignant and non-malignant disorders. However, this technique is still associated with limited numbers of cells for transplantation, and with delayed engraftment of neutrophils and platelets. The field of cord blood transplantation will benefit from enhanced and mechanistically based information on haematopoietic stem cell function and potential means to enhance its effectiveness are reviewed. This includes notions concerning possibility of retrieving more cells from the placenta and cord blood, to expand haematopoietic stem cells ex vivo and to increase efficiency of homing and engraftment of these cells. Also discussed are cryopreservation and long-term storage of cord blood haematopoietic and progenitor cells, and new laboratory findings and animal studies for non-haematopoietic uses of cord blood.
OBJECTIVES: To review information on cord blood banking and transplantation with respect to the author's studies, and in context of this field of investigation. RESULTS: Cord blood transplantation has been successfully used to treat a number of malignant and non-malignant disorders. However, this technique is still associated with limited numbers of cells for transplantation, and with delayed engraftment of neutrophils and platelets. The field of cord blood transplantation will benefit from enhanced and mechanistically based information on haematopoietic stem cell function and potential means to enhance its effectiveness are reviewed. This includes notions concerning possibility of retrieving more cells from the placenta and cord blood, to expand haematopoietic stem cells ex vivo and to increase efficiency of homing and engraftment of these cells. Also discussed are cryopreservation and long-term storage of cord blood haematopoietic and progenitor cells, and new laboratory findings and animal studies for non-haematopoietic uses of cord blood.
Authors: H E Broxmeyer; G W Douglas; G Hangoc; S Cooper; J Bard; D English; M Arny; L Thomas; E A Boyse Journal: Proc Natl Acad Sci U S A Date: 1989-05 Impact factor: 11.205
Authors: Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Bruce R Blazar; Philip B McGlave; Jeffrey S Miller; Catherine M Verfaillie; John E Wagner Journal: Blood Date: 2004-10-05 Impact factor: 22.113
Authors: Claudio G Brunstein; Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Jeffrey S Miller; Bruce R Blazar; Philip B McGlave; John E Wagner Journal: Blood Date: 2007-06-14 Impact factor: 22.113
Authors: Hal E Broxmeyer; Edward F Srour; Giao Hangoc; Scott Cooper; Stacie A Anderson; David M Bodine Journal: Proc Natl Acad Sci U S A Date: 2003-01-07 Impact factor: 11.205
Authors: Hilal Gul-Uludag; Peng Xu; Leah A Marquez-Curtis; James Xing; Anna Janowska-Wieczorek; Jie Chen Journal: Stem Cells Dev Date: 2011-12-14 Impact factor: 3.272
Authors: Saloomeh Mokhtari; Pedro M Baptista; Dipen A Vyas; Charles Jordan Freeman; Emma Moran; Matthew Brovold; Guillermo A Llamazares; Zanneta Lamar; Christopher D Porada; Shay Soker; Graça Almeida-Porada Journal: Stem Cells Transl Med Date: 2018-02-23 Impact factor: 6.940